Archive

But despite the increase, credit quality is expected to remain stable

Registers net profit of Rs 1,391 crores

Posts PAT at Rs 20 crores

Date: January 8-10, 2015Venue: Bangabandhu International Conference Centre, Dhaka, Bangladesh

Date: May 13-15, 2015Venue: Mumbai Exhibition Centre, Mumbai

To be held in Bangalore from September 25 to 27, 2014

EBITDA for Q2CY14 stood at Rs 414 million

Suven Life Sciences achieved a PAT of Rs.34.73 crores for first quarter of 2014-15, an increase of 16.68 per cent compared to same…

LCZ696 significantly reduces cardiovascular deaths in head to head study against enalapril, in addition to current best treatment,…

Plans to launch in the US market in first quarter of 2015

GSK's experimental vaccine has already produced promising results in animal studies

Sales grew by 40 per cent

{source}<div data-configid="5690019/8876212" style="width: 600px; height: 396px;" class="issuuembed"></div><script…

Awarded for their innovative approach to antibody-drug conjugates that may fight cancer

Recognised for ‘Cervical Cancer Screening Programme’

Continues to expand India footprint

Sanofi to market and distribute its oncology portfolio in India

Would be responsible for marketing and sales of Basugine in India

Patents from Australia and Eurasia correspond to the NCEs for the treatment of disorders associated with neurodegenerative…

The services of the clinic will include pre-empting interventions for disease prevention, pre-test genetic counselling and DNA…